THRD logo

Third Harmonic Bio (THRD)

Profile

Full Name

Third Harmonic Bio, Inc.

Ticker Symbol

THRD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 14, 2022

Indexes

Not included

Website

http://www.thirdharmonicbio.com

Employees

53

Key Details

Price

$5.16(+0.58%)

Market cap

$232.74M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.09(-39.74% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.16
THRD price is $5.16

30-Day Relative Volume

0.60
THRD 30-day relative volume is 0.60

Price Performance

Price Most recent change

+0.58%
THRD price was up +0.58% on Apr 17, 2025

Price YTD change

-49.85%
THRD price is down -49.85% since January 1st

Price 1-year change

-54.26%
THRD price is down -54.26% year-on-year

Price 3-year change

-
THRD price 3-year change is unknown

Price Range

Price All-time high

$24.59
THRD price is currently -79.02% below its historical high of $24.59

Price 3-year low

$3.18
THRD price is currently +62.26% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$232.74M
THRD market capitalization is $232.74 million

Market cap 3-year change

-
THRD market capitalization 3-year change is unknown

Market cap All-time high

$941.30M
THRD market capitalization is currently -75.28% below its historical high of $941.30 million

Market cap sector rank

59.46%
THRD market capitalization is higher than 59.46% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+10.67%
THRD shares outstanding is up +10.67% year-on-year

Shares Outstanding 3-Year Change

+22.59%
THRD shares outstanding is up +22.59% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.74
THRD beta is 0.74

200-day SMA

$9.60
THRD price is currently -46.26% below its 200-day simple moving average

50-day SMA

$3.71
THRD price is currently +39.08% above its 50-day simple moving average

RSI

80.43
THRD 14-day relative strength index is 80.43

Volume

0.60
THRD 30-day relative volume is 0.60

ATR

$0.24
THRD average true range is $0.24

10-day Historical Volatility

200.44%
THRD 10-day historical volatility is 200.44%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
THRD annual revenue value is unknown

Revenue Analysts estimate

-
THRD annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
THRD annual revenue 1-year change is unknown

Revenue Sector rank

-
THRD annual revenue is unknown

EPS

EPS

-$1.09
THRD annual earnings per share is -$1.09

EPS Analysts estimate

-$1.04
THRD annual earnings per share is currently +4.81% higher than the consensus analysts' forecast

EPS 1-year change

-39.74%
THRD annual earnings per share is down -39.74% year-on-year

EPS Sector rank

54.27%
THRD annual earnings per share is higher than 54.27% of companies in Healthcare sector

Profit

Gross profit

-
THRD annual gross profit value is unknown

Gross margin

-
THRD annual gross profit margin value is unknown

Operating profit

-$58.87M
THRD annual operating income is -$58.87 million

Operating margin

-
THRD annual operating profit margin value is unknown

Net income

-$45.47M
THRD annual net profit is -$45.47 million

Net margin

-
THRD annual net profit margin value is unknown

Expenses

Total expenses

$58.87M
THRD annual total expenses is $58.87 million

Operating expenses

$58.87M
THRD annual total operating expenses is $58.87 million

Cost of goods sold

-
THRD annual cost of goods sold value is unknown

Selling, general & administrative expenses

$22.37M
THRD annual SGA is $22.37 million

Depreciation and amortization

$49.00K
THRD annual depreciation & amortization is $49.00 thousand

Interest expense

-
THRD annual interest expense value is unknown

Income tax

-
THRD annual income tax value is unknown

EBIT & EBITDA

EBIT

-$58.87M
THRD annual earnings before interest & taxes is -$58.87 million

EBITDA

-$58.82M
THRD annual EBITDA is -$58.82 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$294.61M
THRD annual total assets is $294.61 million

Non current assets

$4.07M
THRD annual long term assets is $4.07 million

Current assets

$290.54M
THRD annual total current assets is $290.54 million

Cash and cash equivalents

$285.06M
THRD annual cash & cash equivalents is $285.06 million

Accounts receivable

-
THRD annual accounts receivable value is unknown

Inventory

-
THRD annual inventory value is unknown

Liabilities

Total liabilities

$9.46M
THRD annual total liabilities is $9.46 million

Long term liabilities

$2.35M
THRD annual total long term liabilities is $2.35 million

Current liabilities

$7.11M
THRD annual total current liabilities is $7.11 million

Accounts payable

$1.94M
THRD annual accounts payable is $1.94 million

Debt

Total debt

$3.21M
THRD annual total debt is $3.21 million

Total debt 1-year change

-18.85%
THRD annual total debt is down -18.85% year-on-year

Long term debt

$2.35M
THRD annual long term debt is $2.35 million

Short term debt

$859.00K
THRD annual short term debt is $859.00 thousand

Equity & Capital

Shareholders equity

$285.15M
THRD annual stockholders equity is $285.15 million

Book value

$285.15M
THRD annual book value is $285.15 million

Retained earnings

-$159.69M
THRD annual retained earnings is -$159.69 million

Working capital

$283.43M
THRD annual working capital is $283.43 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$34.50M
THRD annual cash flow from operations is -$34.50 million

Cash from operations 1-year change

-68.93%
THRD annual cash flow from operations is down -68.93% year-on-year

Cash from investing

-$10.00K
THRD annual cash flow from investing activities is -$10.00 thousand

Cash from investing 1-year change

+94.08%
THRD annual cash flow from investing activities is up +94.08% year-on-year

Cash from financing

$50.51M
THRD annual cash flow from financing activities is $50.51 million

Cash from financing 1-year change

+6221.15%
THRD annual cash flow from financing activities is up +6221.15% year-on-year

CAPEX

CAPEX

-
THRD annual capital expenditures value is unknown

CAPEX 1-year change

-
THRD annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$34.51M
THRD annual free cash flow is -$34.51 million

Free cash flow 1-year change

-67.59%
THRD annual free cash flow is down -67.59% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
THRD annual gross profit margin value is unknown

Operating margin

-
THRD annual operating profit margin value is unknown

Net margin

-
THRD annual net profit margin value is unknown

ROA & ROE

ROA

-15.43%
THRD annual return on assets is -15.43%

ROE

-15.95%
THRD annual return on equity is -15.95%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
THRD price to earnings ratio value is unknown

PE ratio Sector rank

-
THRD price to earnings ratio is unknown

PB Ratio

PB ratio

0.82
THRD price to book ratio is 0.82

PB ratio Sector rank

40.61%
THRD price to book ratio is higher than 40.61% of companies in Healthcare sector

PS Ratio

PS ratio

-
THRD price to sales ratio value is unknown

PS ratio Sector rank

-
THRD price to sales ratio is unknown

Enterprise value

Enterprise value

-$49.12M
THRD enterprise value is -$49.12 million

Enterprise value Sector rank

1.65%
THRD enterprise value is higher than 1.65% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.84
THRD EV/EBITDA is 0.84

EV/EBITDA Sector rank

74.43%
THRD EV/EBITDA is higher than 74.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

40.87
THRD annual current ratio is 40.87

Quick ratio

-
THRD annual quick ratio value is unknown

Leverage

Debt to equity

0.01
THRD annual debt to equity ratio is 0.01

Interest coverage ratio

-
THRD annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
THRD piotroski f-score value is unknown

Altman Z-Score

-
THRD altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 28, 25 Stifel
Hold
Feb 12, 25 Morgan Stanley
Equal-Weight
Feb 11, 25 Raymond James
Market Perform
Aug 9, 24 Morgan Stanley
Overweight
Jun 18, 24 Stifel
Buy
Jun 7, 24 Raymond James
Outperform
Aug 11, 23 Morgan Stanley
Equal-Weight
Dec 16, 22 Morgan Stanley
Equal-Weight
Dec 16, 22 Jefferies
Hold
Oct 10, 22 Morgan Stanley
Overweight

Institutional Ownership

Similar stocks

DRUG logo
Bright Minds Biosciences (DRUG)
ABEO logo
Abeona Therapeutics (ABEO)
MBX Biosciences (MBX)
Atlantic International (ATLN)
LFCR logo
Lifecore Biomedical (LFCR)
ATXS logo
Astria Therapeutics (ATXS)
NYXH logo
Nyxoah SA (NYXH)
IMMP logo
Immutep Limited (IMMP)
NVRO logo
Nevro (NVRO)
  • What is the ticker symbol for Third Harmonic Bio?
  • Does Third Harmonic Bio pay dividends?
  • What sector is Third Harmonic Bio in?
  • What industry is Third Harmonic Bio in?
  • What country is Third Harmonic Bio based in?
  • When did Third Harmonic Bio go public?
  • Is Third Harmonic Bio in the S&P 500?
  • Is Third Harmonic Bio in the NASDAQ 100?
  • Is Third Harmonic Bio in the Dow Jones?
  • When was Third Harmonic Bio's last earnings report?
  • When does Third Harmonic Bio report earnings?
  • Should I buy Third Harmonic Bio stock now?

What is the ticker symbol for Third Harmonic Bio?

The ticker symbol for Third Harmonic Bio is NASDAQ:THRD

Does Third Harmonic Bio pay dividends?

No, Third Harmonic Bio does not pay dividends

What sector is Third Harmonic Bio in?

Third Harmonic Bio is in the Healthcare sector

What industry is Third Harmonic Bio in?

Third Harmonic Bio is in the Biotechnology industry

What country is Third Harmonic Bio based in?

Third Harmonic Bio is headquartered in United States

When did Third Harmonic Bio go public?

Third Harmonic Bio's initial public offering (IPO) was on September 14, 2022

Is Third Harmonic Bio in the S&P 500?

No, Third Harmonic Bio is not included in the S&P 500 index

Is Third Harmonic Bio in the NASDAQ 100?

No, Third Harmonic Bio is not included in the NASDAQ 100 index

Is Third Harmonic Bio in the Dow Jones?

No, Third Harmonic Bio is not included in the Dow Jones index

When was Third Harmonic Bio's last earnings report?

Third Harmonic Bio's most recent earnings report was on Mar 27, 2025

When does Third Harmonic Bio report earnings?

The next expected earnings date for Third Harmonic Bio is May 15, 2025

Should I buy Third Harmonic Bio stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page